Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Development of a New Method for Liver Stiffness Measurement Using FibroScan

NCT: NCT06519331 · RECRUITING

NCT IDNCT06519331
StatusRECRUITING
Start Date2024-11-08
Completion2027-12-01
SponsorEchosens (INDUSTRY)
First posted
Last updated

Brief Summary

This is an European, prospective, interventional, multicenter clinical investigation that will take place in 2 French sites. 153 adults patients will be included. The study objective is to develop a new method for measuring liver stiffness using FibroScan.

Frequently Asked Questions

What is Development of a New Method for Liver Stiffness Measurement Using FibroScan?

Development of a New Method for Liver Stiffness Measurement Using FibroScan is a clinical trial registered under NCT06519331. Current status: RECRUITING.

What is the status of NCT06519331?

The current status of NCT06519331 (Development of a New Method for Liver Stiffness Measurement Using FibroScan) is: RECRUITING.

When did Development of a New Method for Liver Stiffness Measurement Using FibroScan start?

Development of a New Method for Liver Stiffness Measurement Using FibroScan started on 2024-11-08.

Related Devices

K160524FibroScan 530 CompactEchosens K172142FibroScan 430 Mini+Echosens K173034FibroScan® Family of Products (Models: 502 Touch, 530 Compact, and 430 Mini+)Echosens K181547FibroScan® Family of Products (Models: 502 Touch, 530 Compact, and 430 Mini+)Echosens K200655FibroScan® 630Echosens

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑